WINDSOR, Connecticut – SCA Pharmaceuticals, a leading national provider of 503B outsourced pharmaceuticals, announced the business has rebranded to SCA Pharma. The comprehensive rebrand elevates SCA’s focus on quality, innovation and customer service.
As part of this initiative, SCA has launched a new website www.scapharma.com. Developed to be a customer-centric resource, this site is only the beginning of a large 2018 digital initiative which includes several projects to expedite and simplify customers’ experiences which will roll through the rest of the year.
“This is another vital step in the evolution of SCA” stated Milton Boyer, CEO. “We opened a 90,000 square foot production facility at the end of 2017 which gave us the ability to produce more product, and now it is vital that we implement the technological measures to ensure customers can efficiently learn about and order those new products.”
The growth of SCA Pharma has been a combination of a customer-centric approach, attention to detail, and upgrading of processes and operations that allows streamlining of the entire production system. This is in part an effort to increase its broader appeal and reach in the market, thereby allowing for a better competitive advantage. The changes being implemented are multifaceted, covering a wide range of company-wide applications.
However, they are just the starting point for SCA Pharma. With continued improvements, effort, and research, the company’s aim is to maintain a leading position in the compounding pharmacy marketplace. SCA continues to lead the way in Quality, Reliability, Compliance, and Passion.
For any further information about SCA Pharma or their products, you can contact them through the details available on the company’s website.
About SCA Pharma
SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and prefilled syringes. Licensed in all 50 states, SCA offers a robust catalog, as well as outstanding quality and customer service. Since day 1, SCA has performed 100% final product sterility testing with lot-specific lab reports for every sterile product produced. SCA additionally performs environmental monitoring and full endotoxin testing on every batch of sterile products, prior to release, fulfilling requirements for Endotoxin (Pyrogen) testing per USP Guidelines and cGMP guidance.
For more information, visit www.scapharma.com.
Media Contact
Company Name: SCA Pharma
Contact Person: Brenden Roche
Email: Send Email
Phone: 860-697-3622
Address:755 Rainbow Road Suite B
City: Windsor
State: CT, 06095
Country: United States
Website: http://www.scapharma.com/